CentriMag Circulatory Support System
Abbott · Decision date Oct 2, 2026
What did the FDA decide?
The FDA database entry P170038/S033 records a 30-day notice for Abbott's CentriMag Circulatory Support System, classified under product code DSQ for ventricular assist bypass in cardiovascular devices. The reported change is the addition of "an additional second-tier supplier of the CentriMag Motor Protection Cup component," with the supplement reason labeled as a process change covering manufacturer, sterilizer, packager, or supplier. This describes a supply-chain arrangement for one named component, not a modification to the device's approved design or labeling.
Because S033 is a supplement to PMA P170038, it sits within that original approval rather than constituting a new approval of the CentriMag system as a whole. The source statement gives the component and the supplier tier but does not name the supplier, describe qualification testing, or present data bearing on safety or clinical effectiveness; the notice's purpose is regulatory reporting of the change, and should not be read as independent confirmation of either.
FDA approval order statement
an additional second-tier supplier of the CentriMag Motor Protection Cup component
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 2, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P170038/S033
- Regulatory pathway
- PMA supplement
- Applicant
- Abbott
- Product code
- DSQ
- Decision code
- OK30
- Decision date
- Oct 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
For the original device and its historical approval scope, see PMA P170038. Subsequent supplements may change the device or its indications.
FDA decision timeline
P170038 · Original PMA
CentriMag Circulatory Support System
P170038/S032 · Related supplement
CentriMag Circulatory Support System
P170038/S033 received
Application receipt date recorded by FDA.
P170038/S033 · FDA decision
30-Day Notice
P170038/S034 · Related supplement
CentriMag Circulatory Support System
Timeline entries are records held by MedtechLedger for P170038. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170038
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Abbott | PMA approval | Dec 6, 2019 | FDA | |
CentriMag Circulatory Support SystemP170038/S032 | Abbott | PMA supplement | Sep 2, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S034 | Abbott | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
EXCOR Pediatric VADP160035/S056 | Berlin Heart, Inc. | PMA supplement | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 6035 Stoneridge Dr., Pleasanton, CA, 94588
Sources and methodology
- Original FDA record: P170038/S033
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




